EKF Diagnostics Holdings Statistics
Want to see GB:EKF full AI Analyst Report?
EKF Diagnostics Holdings (EKF) Stock Statistics & Valuation Metrics
Total Valuation
EKF Diagnostics Holdings has a market cap or net worth of GBX 104.42M. The enterprise value is GBX 103.24M.
- Market Cap
- GBX 104.42M
- Enterprise Value
- GBX 103.24M
Share Statistics
EKF Diagnostics Holdings has 427,968,380 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 427,968,380
- Owned by Insiders
- 30.11%
- Owned by Institutions
- 0.26%
Financial Efficiency
EKF Diagnostics Holdings’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 3.36%.
- Return on Equity (ROE)
- 0.03
- Return on Assets (ROA)
- 0.03
- Return on Invested Capital (ROIC)
- 3.36%
- Return on Capital Employed (ROCE)
- 0.09
- Revenue Per Employee
- 167.42K
- Profits Per Employee
- 6,889.61
- Employee Count
- 308
- Asset Turnover
- 0.64
- Inventory Turnover
- 3.02
Valuation Ratios
The current PE Ratio of EKF Diagnostics Holdings is 41.38. EKF Diagnostics Holdings’s PEG ratio is -0.73.
- PE Ratio
- 41.38
- PS Ratio
- 2.00
- PB Ratio
- 1.47
- Price to FCF
- 16.57
- Price to Operating Cash Flow
- 12.76
- PEG Ratio
- -0.73
Income Statement
In the last 12 months, EKF Diagnostics Holdings had revenue of 51.56M and earned 2.12M in profits. Earnings per share was 0.00.
- Revenue
- 51.56M
- Gross Profit
- 26.48M
- Operating Income
- 6.98M
- Pretax Income
- 7.09M
- Net Income
- 2.12M
- EBITDA
- 12.40M
- Earnings Per Share (EPS)
- 0.00
Cash Flow
In the last 12 months, operating cash flow was 8.11M and capital expenditures -1.91M, giving a free cash flow of 6.20M billion.
- Operating Cash Flow
- 8.11M
- Free Cash Flow
- 6.20M
- Free Cash Flow per Share
- 0.01
Dividends & Yields
EKF Diagnostics Holdings pays an annual dividend of GBX 1.20, resulting in a dividend yield of ―
- Dividend Per Share
- GBX 1.20
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 6.03%
- Earnings Yield
- 2.41%
Stock Price Statistics
- Beta
- 0.16
- 52-Week Price Change
- -7.34%
- 50-Day Moving Average
- 24.77
- 200-Day Moving Average
- 25.39
- Relative Strength Index (RSI)
- 46.41
- Average Volume (3m)
- 386.59K
Important Dates
EKF Diagnostics Holdings upcoming earnings date is Mar 30, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Sep 15, 2026
- Next Earnings Date
- Mar 30, 2027
- Ex-Dividend Date
- Nov 02, 2023
Financial Position
EKF Diagnostics Holdings as a current ratio of 4.16, with Debt / Equity ratio of 2.01%
- Current Ratio
- 4.16
- Quick Ratio
- 3.04
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -1.17
- Interest Coverage Ratio
- 45.31
Taxes
In the past 12 months, EKF Diagnostics Holdings has paid 4.55M in taxes.
- Income Tax
- 4.55M
- Effective Tax Rate
- 0.64
Enterprise Valuation
EKF Diagnostics Holdings EV to EBITDA ratio is 7.18, with an EV/FCF ratio of 14.23.
- EV to Sales
- 1.72
- EV to EBITDA
- 7.18
- EV to Free Cash Flow
- 14.23
- EV to Operating Cash Flow
- 10.88
Balance Sheet
EKF Diagnostics Holdings has GBX 15.97M in cash and marketable securities with GBX 1.47M in debt, giving a net cash position of GBX 14.50M billion.
- Cash & Marketable Securities
- GBX 15.97M
- Total Debt
- GBX 1.47M
- Net Cash
- GBX 14.50M
- Net Cash Per Share
- GBX 0.03
- Tangible Book Value Per Share
- GBX 0.10
Margins
Gross margin is 52.74%, with operating margin of 13.25%, and net profit margin of 4.86%.
- Gross Margin
- 52.74%
- Operating Margin
- 13.25%
- Pretax Margin
- 13.40%
- Net Profit Margin
- 4.86%
- EBITDA Margin
- 23.93%
- EBIT Margin
- 13.25%
Analyst Forecast
The average price target for EKF Diagnostics Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 2.26%
- EPS Growth Forecast
- -57.04%
Scores
- Smart Score
- 3
- AI Score
- 64
